The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Ca2+Channel Subtypes and Pharmacology in the Kidney
Open accessAbstract
A large body of evidence has accrued indicating that voltage-gated Ca 2+channel subtypes, including L-, T-, N-, and P/Q-type, are present within renal vascular and tubular tissues, and the blockade of these Ca 2+channels produces diverse actions on renal microcirculation. Because nifedipine acts exclusively on L-type Ca 2+channels, the observation that nifedipine predominantly dilates afferent arterioles implicates intrarenal heterogeneity in the distribution of L-type Ca 2+channels and suggests that it potentially causes glomerular hypertension. In contrast, recently developed Ca 2+channel blockers (CCBs), including mibefradil and efonidipine, exert blocking action on L-type and T-type Ca 2+channels and elicit vasodilation of afferent and efferent arterioles, which suggests the presence of T-type Ca 2+channels in both arterioles and the distinct impact on intraglomerular pressure. Recently, aldosterone has been established as an aggravating factor in kidney disease, and T-type Ca 2+channels mediate aldosterone release as well as its effect on renal efferent arteriolar tone. Furthermore, T-type CCBs are reported to exert inhibitory action on inflammatory process and renin secretion. Similarly, N-type Ca 2+channels are present in nerve terminals, and the inhibition of neurotransmitter release by N-type CCBs (eg, cilnidipine) elicits dilation of afferent and efferent arterioles and reduces glomerular pressure. Collectively, the kidney is endowed with a variety of Ca 2+channel subtypes, and the inhibition of these channels by their specific CCBs leads to variable impact on renal microcirculation. Furthermore, multifaceted activity of CCBs on T- and N-type Ca 2+channels may offer additive benefits through nonhemodynamic mechanisms in the progression of chronic kidney disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.23.2981 · Cited by 5,664
Effectiveness of Aldosterone Blockade in Patients With Diabetic Nephropathy
Sato, A., Hayashi, K., Naruse, M., & Saruta, T. (2003) · Hypertension · doi:10.1161/01.hyp.0000044937.95080.e9 · Cited by 466
Self-citation
Cited by
Pathogenesis and Treatment of Chronic Kidney Disease: A Review of Our Recent Basic and Clinical Data
Tomino, Y. (2014) · Kidney and Blood Pressure Research · doi:10.1159/000368458 · Cited by 566
Renal Autoregulation in Health and Disease
Carlström, M., Wilcox, C. S., & Arendshorst, W. J. (2015) · Physiological Reviews · doi:10.1152/physrev.00042.2012 · Cited by 485
A Genome-Wide Association Study of Hypertension and Blood Pressure in African Americans
Adeyemo, A., Gerry, N., Chen, G., Herbert, A., Doumatey, A., Huang, H., Zhou, J., Lashley, K., Chen, Y., Christman, M., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000564 · Cited by 392
Chitosan-Alginate Nanoparticles as a Novel Drug Delivery System for Nifedipine
The Second Hospital of Lanzhou University, L., Li, P., Dai, Y.-N., Pharmacy College of Lanzhou University, L., Zhang, J.-P., Lanzhou Institute of Chemical Physics, C. A. O. S., Wei, Q., & The Second Hospital of Lanzhou University, L. (2008) · International Journal of Biomedical Science · doi:10.59566/ijbs.2008.4221 · Cited by 386
Hallow, K. M., Lo, A., Beh, J., Rodrigo, M., Ermakov, S., Friedman, S., de Leon, H., Sarkar, A., Xiong, Y., Sarangapani, R., et al. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00039.2013 · Cited by 68
Metadata
- Authors
- Hayashi, K., Wakino, S., Sugano, N., Ozawa, Y., Homma, K., & Saruta, T.
- Venue
- Circulation Research
- Published
- 2007-02-16
- Volume
- 100
- Issue
- 3
- Pages
- 342-353
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2104005164
- Cited by
- 206
- References
- 2
- FWCI
- 6.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ca2+Channel Subtypes and Pharmacology in the Kidney. https://app.cochat.ai/papers/10.1161/01.res.0000256155.31133.49
- The paper
- Hayashi, K., Wakino, S., Sugano, N., Ozawa, Y., Homma, K., & Saruta, T. (2007). Ca2+Channel Subtypes and Pharmacology in the Kidney. Circulation Research. https://doi.org/10.1161/01.res.0000256155.31133.49
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.